Insider transaction feed
Latest SEC Form 4 insider trades with explainable signal scoring.
2,945 transactions Export CSV
Buy volume
$591.21M
1495 buy transactions
Sell volume
$2.11B
1450 sell transactions
Net flow
-$1.51B
Net selling
Total flow
$2.70B
2945 priced transactions
Net insider flow· last 30 days
Buys Sellsnet -$1.52B
Convergence— where independent disclosures line up
View all signals →
| Transaction | Flags | ||||||||
|---|---|---|---|---|---|---|---|---|---|
3d ago Jun 24, 2026 | Snowflake Inc. | Ho Emily Chief Accounting Officer | Sell · S | 1,860 | $232.25 | $432.0K | Neutral-13 | ||
3d ago Jun 24, 2026 | Context Therapeutics Inc. | Smith Karen L. Director | Buy · A | 45,000 | $0.00 | $0 | Neutral+2 | Deriv | |
3d ago Jun 25, 2026 | Spyre Therapeutics, Inc. | Burrows Scott L Chief Financial Officer | Buy · M | 15,000 | $0.00 | $0 | Mild sell-16 | Deriv | |
3d ago Jun 25, 2026 | Spyre Therapeutics, Inc. | Burrows Scott L Chief Financial Officer | Sell · S | 10,000 | $87.14 | $871.4K | Mild sell-16 | ||
3d ago Jun 25, 2026 | Spyre Therapeutics, Inc. | Burrows Scott L Chief Financial Officer | Sell · S | 5,000 | $87.12 | $435.6K | Mild sell-16 | ||
3d ago Jun 25, 2026 | Spyre Therapeutics, Inc. | Burrows Scott L Chief Financial Officer | Buy · M | 15,000 | $14.50 | $217.5K | Mild sell-16 | ||
3d ago Jun 24, 2026 | 26North BDC, Inc. | McGovern, Brendan President and CEO · Director | Buy · A | 20,163 | $24.80 | $500.0K | Neutral+6 | ||
3d ago Jun 24, 2026 | 26North BDC, Inc. | Yu, David Vice President | Buy · A | 4,033 | $24.80 | $100.0K | Neutral+5 | ||
3d ago Jun 24, 2026 | Roivant Sciences Ltd. | Venker Eric President & Immunovant CEO | Buy · M | 200,000 | $0.00 | $0 | Mild sell-20 | Deriv | |
3d ago Jun 24, 2026 | Roivant Sciences Ltd. | Venker Eric President & Immunovant CEO | Sell · S | 46,234 | $33.51 | $1.55M | Mild sell-20 | ||
3d ago Jun 24, 2026 | Roivant Sciences Ltd. | Venker Eric President & Immunovant CEO | Sell · S | 153,766 | $33.05 | $5.08M | Mild sell-20 | ||
3d ago Jun 24, 2026 | Roivant Sciences Ltd. | Venker Eric President & Immunovant CEO | Buy · M | 200,000 | $3.85 | $770.0K | Mild sell-20 | ||
3d ago Jun 24, 2026 | American Healthcare REIT, Inc. | Foster Mark E. EVP, GC & Secretary | Sell · S | 2,500 | $48.58 | $121.5K | Mild sell-16 | ||
3d ago Jun 24, 2026 | American Healthcare REIT, Inc. | Richardson Valerie Director | Buy · A | 2,594 | $0.00 | $0 | Neutral+2 | ||
3d ago Jun 24, 2026 | American Healthcare REIT, Inc. | O'Quinn Marvin R Director | Buy · A | 2,594 | $0.00 | $0 | Neutral+2 | ||
3d ago Jun 24, 2026 | American Healthcare REIT, Inc. | Smith Wilbur H III Director | Buy · A | 2,594 | $0.00 | $0 | Neutral+2 | ||
3d ago Jun 24, 2026 | American Healthcare REIT, Inc. | Flornes Brian J. Director | Buy · A | 2,594 | $0.00 | $0 | Neutral+2 | ||
3d ago Jun 24, 2026 | American Healthcare REIT, Inc. | Hurley Dianne Director | Buy · A | 2,594 | $0.00 | $0 | Neutral+2 | ||
3d ago Jun 26, 2026 | Contineum Therapeutics, Inc. | Boyce Sarah Director | Buy · A | 19,000 | $0.00 | $0 | Neutral+2 | Deriv | |
3d ago Jun 24, 2026 | AdaptHealth Corp. | Lundberg Theodore B. Director | Buy · A | 18,999 | $0.00 | $0 | Neutral+2 | ||
3d ago Jun 24, 2026 | Revolution Medicines, Inc. | Anders Jack Chief Financial Officer | Buy · M | 20,000 | $0.00 | $0 | Neutral-4 | 10b5-1Deriv | |
3d ago Jun 24, 2026 | Revolution Medicines, Inc. | Anders Jack Chief Financial Officer | Sell · S | 300 | $170.32 | $51.1K | Neutral-4 | 10b5-1 | |
3d ago Jun 24, 2026 | Revolution Medicines, Inc. | Anders Jack Chief Financial Officer | Sell · S | 5,651 | $169.24 | $956.4K | Neutral-4 | 10b5-1 | |
3d ago Jun 24, 2026 | Revolution Medicines, Inc. | Anders Jack Chief Financial Officer | Sell · S | 9,496 | $168.20 | $1.60M | Neutral-4 | 10b5-1 | |
3d ago Jun 24, 2026 | Revolution Medicines, Inc. | Anders Jack Chief Financial Officer | Sell · S | 4,553 | $167.35 | $761.9K | Neutral-4 | 10b5-1 | |
3d ago Jun 24, 2026 | Revolution Medicines, Inc. | Anders Jack Chief Financial Officer | Buy · M | 20,000 | $18.56 | $371.2K | Neutral-4 | 10b5-1 | |
3d ago Jun 26, 2026 | Immunovant, Inc. | Girao Tiago Chief Financial Officer | Buy · M | 10,000 | $0.00 | $0 | Neutral-12 | Deriv | |
3d ago Jun 26, 2026 | Immunovant, Inc. | Girao Tiago Chief Financial Officer | Sell · S | 10,000 | $38.46 | $384.6K | Neutral-12 | ||
3d ago Jun 26, 2026 | Immunovant, Inc. | Girao Tiago Chief Financial Officer | Buy · M | 10,000 | $15.90 | $159.0K | Neutral-12 | ||
3d ago Jun 25, 2026 | ZIPRECRUITER, INC. | SAKAMOTO RYAN T. EVP, Chief Legal Officer | Sell · S | 2,978 | $3.86 | $11.5K | Neutral+7 | 10b5-1 | |
3d ago Jun 26, 2026 | Omada Health, Inc. | Duffy Sean P. Chief Executive Officer · Director | Sell · S | 4,314 | $20.90 | $90.2K | Neutral+8 | 10b5-1 | |
3d ago Jun 26, 2026 | Omada Health, Inc. | Duffy Sean P. Chief Executive Officer · Director | Sell · S | 9,844 | $19.61 | $193.0K | Neutral+8 | 10b5-1 | |
3d ago Jun 25, 2026 | Omada Health, Inc. | Duffy Sean P. Chief Executive Officer · Director | Sell · S | 300 | $19.00 | $5.7K | Neutral+8 | 10b5-1 | |
3d ago Jun 24, 2026 | Omada Health, Inc. | Duffy Sean P. Chief Executive Officer · Director | Sell · S | 2,800 | $19.01 | $53.2K | Neutral+8 | 10b5-1 | |
3d ago Jun 24, 2026 | Omada Health, Inc. | Gracey Craig Chief Accounting Officer | Sell · S | 2,083 | $19.01 | $39.6K | Neutral+7 | 10b5-1 | |
3d ago Jun 25, 2026 | Omada Health, Inc. | Cook Steven L. Chief Financial Officer | Sell · S | 300 | $19.00 | $5.7K | Neutral+7 | 10b5-1 | |
3d ago Jun 24, 2026 | Omada Health, Inc. | Cook Steven L. Chief Financial Officer | Sell · S | 2,600 | $19.02 | $49.4K | Neutral+7 | 10b5-1 | |
3d ago Jun 24, 2026 | Natera, Inc. | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sell · S | 11,130 | $253.39 | $2.82M | Mild sell-20 | ||
3d ago Jun 24, 2026 | Natera, Inc. | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sell · S | 5,066 | $252.31 | $1.28M | Mild sell-20 | ||
3d ago Jun 24, 2026 | Natera, Inc. | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sell · S | 1,200 | $251.60 | $301.9K | Mild sell-20 | ||
3d ago Jun 24, 2026 | Natera, Inc. | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sell · S | 16,204 | $250.25 | $4.06M | Mild sell-20 | ||
3d ago Jun 24, 2026 | LA-Z-BOY INC | Whittington Melinda D President & CEO · Director | Sell · F | 5,096 | $41.85 | $213.3K | Neutral+6 | ||
3d ago Jun 24, 2026 | ARVINAS, INC. | Smaldone Alsup Laurie Director | Buy · A | 22,714 | $0.00 | $0 | Neutral+2 | Deriv | |
3d ago Jun 24, 2026 | ARVINAS, INC. | Smaldone Alsup Laurie Director | Buy · A | 15,527 | $0.00 | $0 | Neutral+2 | ||
3d ago Jun 25, 2026 | Rush Street Interactive, Inc. | Sauers Kyle Chief Financial Officer | Buy · M | 46,728 | $0.00 | $0 | Neutral+5 | Deriv | |
3d ago Jun 25, 2026 | Rush Street Interactive, Inc. | Sauers Kyle Chief Financial Officer | Buy · M | 46,728 | $3.28 | $153.3K | Neutral+5 | ||
3d ago Jun 25, 2026 | Rush Street Interactive, Inc. | Sauers Kyle Chief Financial Officer | Sell · G | 2,460 | $0.00 | $0 | Neutral+5 | ||
3d ago Jun 25, 2026 | SentinelOne, Inc. | Hughes Aaron Director | Buy · A | 14,238 | $0.00 | $0 | Neutral+2 | ||
3d ago Jun 25, 2026 | SentinelOne, Inc. | Hughes Aaron Director | Buy · A | 4,176 | $0.00 | $0 | Neutral+2 | ||
3d ago Jun 25, 2026 | SentinelOne, Inc. | Scheinman Daniel Director | Buy · A | 14,238 | $0.00 | $0 | Neutral+2 |
